Work

Homologous recombination deficiency real-time clinical assays, ready or not?

Year: 2020

Type: review

Source: Gynecologic Oncology

DOI: 10.1016/j.ygyno.2020.08.035

Authors: Katherine Fuh, Mary Mullen, Barbara Blachut, Elizabeth Stover, Panagiotis Konstantinopoulos, Joyce Liu, Ursula Matulonis, Dineo Khabele, Nima Mosammaparast, Alessandro Vindigni

Institutions: Washington University in St. Louis, Alvin J. Siteman Cancer Center, Harvard University, Dana-Farber Cancer Institute

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Merck, Eisai, National Cancer Institute

Award: The roles of anti-apoptotic proteins BCL-XL and MCL1 in mediating survival of high-grade serous ovarian cancer following drug-induced DNA damage

OpenAlex ID: W3087202676

FWCI: 1.154

Cites: 71

Cited by: 71

Related to: 10